Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Novartis AG (NVSEF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
83.7480 -0.9520    -1.12%
11/08 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 600
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 83.6000 - 84.3500
Novartis 83.7480 -0.9520 -1.12%
IndustryPharmaceuticals
SectorHealthcare
Employees

110000

Equity Type

ORD

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Contact Information

Phone 41 61 324 1111
Fax 41 61 324 8001

Top Executives

Name Age Since Title
Joerg Reinhardt 66 1999 Independent Non-Executive Chairman
Daniel L. Vasella 69 1996 Honorary Chairman
William Thomas Winters 61 2013 Independent Non-Executive Director
Charles L. Sawyers 63 2013 Independent Non-Executive Director
Nancy C. Andrews 64 2015 Independent Non-Executive Director
Bridgette P. Heller 61 2020 Independent Non-Executive Director
François Adrianus van Houten 62 2017 Independent Non-Executive Director
Simon E. Moroney 63 2020 Independent Vice Chairman of the Board
Ana de Pro Gonzalo - 2022 Director
Daniel Hochstrasser - 2022 Independent Director
Andreas von Planta 67 2006 Independent Non-Executive Director
Ton Buechner 57 2016 Independent Non-Executive Director
Elizabeth Doherty 65 2016 Independent Non-Executive Director
Patrice Bula 66 2019 Lead Independent Director
Sidonie Golombowski-Daffner - - Chairperson & President of Advanced Accelerator Applications
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVN Comments

Write your thoughts about Novartis AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Nelson Christopherson
Nelson Christopherson Jul 08, 2022 0:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This is the perfect time to invest in cryptocurrency now that bitcoin is on the falling side, from analysis bitcoin will soon rise to the highest side very soon.It’s good to save money but wise to invest cause your money works for you.I will recommend my current trader Mrs Annabella Ryan, her strategies are earning alot of profits for me. I have earned over $150,000 investing with her.She gives her clients access to her trading site whereby they can monitor their trades on daily basis. Reach her on Instagram👉💓✅✅✅@annabellaryan_official_tradet
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email